These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23355491)

  • 21. AIDS vaccine 'needs focused effort' as drug firms back off research.
    Butler D
    Nature; 1995 Nov; 378(6555):323-4. PubMed ID: 7477355
    [No Abstract]   [Full Text] [Related]  

  • 22. Public and private donor financing for health in developing countries.
    Howard LM
    Infect Dis Clin North Am; 1991 Jun; 5(2):221-34. PubMed ID: 1869807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Justice in the application of science: beyond fair benefits.
    London AJ
    Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976
    [No Abstract]   [Full Text] [Related]  

  • 24. Panel discussion on vaccine development to meet U.S. and international needs. Strategies for reducing the disincentives to HIV vaccine development: description of a successful public-private sector international collaboration.
    Bronnenkant L
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S311-3. PubMed ID: 7865329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The International AIDS Vaccine Initiative.
    Berkley S
    J Int Assoc Physicians AIDS Care; 1997 Nov; 3(11):30-4. PubMed ID: 11364811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gates of opportunity.
    Sorenson E
    Nature; 2007 May; 447(7143):502-3. PubMed ID: 17554811
    [No Abstract]   [Full Text] [Related]  

  • 27. The perverse consequences of a proposed global tax on research.
    MacDonald C; Walton N
    Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
    [No Abstract]   [Full Text] [Related]  

  • 28. WHO plans for neglected diseases are wrong.
    Moran M
    Nature; 2014 Feb; 506(7488):267. PubMed ID: 24553204
    [No Abstract]   [Full Text] [Related]  

  • 29. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.
    Jadhav S; Datla M; Kreeftenberg H; Hendriks J
    Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial lessons from public-private partnerships in drug and vaccine development.
    Wheeler C; Berkley S
    Bull World Health Organ; 2001; 79(8):728-34. PubMed ID: 11545329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health innovation networks to help developing countries address neglected diseases.
    Morel CM; Acharya T; Broun D; Dangi A; Elias C; Ganguly NK; Gardner CA; Gupta RK; Haycock J; Heher AD; Hotez PJ; Kettler HE; Keusch GT; Krattiger AF; Kreutz FT; Lall S; Lee K; Mahoney R; Martinez-Palomo A; Mashelkar RA; Matlin SA; Mzimba M; Oehler J; Ridley RG; Senanayake P; Singer P; Yun M
    Science; 2005 Jul; 309(5733):401-4. PubMed ID: 16020723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From construction workers to architects: developing scientific research capacity in low-income countries.
    Coloma J; Harris E
    PLoS Biol; 2009 Jul; 7(7):e1000156. PubMed ID: 19621063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.
    Perdue ML; Bright RA
    Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The landscape in global tobacco control research: a guide to gaining a foothold.
    Lando HA; Borrelli B; Klein LC; Waverley LP; Stillman FA; Kassel JD; Warner KE
    Am J Public Health; 2005 Jun; 95(6):939-45. PubMed ID: 15914813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ambitious AIDS grants deepen rift between researchers.
    Basu P
    Nat Med; 2006 Aug; 12(8):865. PubMed ID: 16892015
    [No Abstract]   [Full Text] [Related]  

  • 36. The impact of an AIDS vaccine in developing countries: a new model and initial results.
    Stover J; Bollinger L; Hecht R; Williams C; Roca E
    Health Aff (Millwood); 2007; 26(4):1147-58. PubMed ID: 17630459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The distribution of biomedical research resources and international justice.
    Resnik DB
    Dev World Bioeth; 2004 May; 4(1):42-57. PubMed ID: 15086373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The PAL+ program, an incentive concerted action about malaria and associated infectious diseases, for developing countries].
    Agid F
    J Soc Biol; 2004; 198(3):207-11. PubMed ID: 15662937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global perspectives on vaccine financing.
    Berman S; Giffin RB
    Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AIDS vaccine research focuses on subtypes in developed world.
    Sharma R
    BMJ; 2000 Sep; 321(7264):787. PubMed ID: 11009513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.